SEC Filings

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.

Filing date Form Description View
3

Initial filing by director officer or owner of more than ten percent.

View HTML
3

Initial filing by director officer or owner of more than ten percent.

View HTML
3

Initial filing by director officer or owner of more than ten percent.

View HTML
3

Initial filing by director officer or owner of more than ten percent.

View HTML
3

Initial filing by director officer or owner of more than ten percent.

View HTML
10-12B/A

Amendment to a previously filed 10-12B

View HTML
10-12B/A

Amendment to a previously filed 10-12B

View HTML
10-12B/A

Amendment to a previously filed 10-12B

View HTML
10-12B/A

Amendment to a previously filed 10-12B

View HTML
10-12B/A

Amendment to a previously filed 10-12B

View HTML

Copyright Morningstar